Search

Your search keyword '"Al-Ahmad, M"' showing total 350 results

Search Constraints

Start Over You searched for: Author "Al-Ahmad, M" Remove constraint Author: "Al-Ahmad, M"
350 results on '"Al-Ahmad, M"'

Search Results

1. Interleukin-4 (C590T) Gene Polymorphism in Association with Asthma Severity

2. Adult Severe Asthma Registries: A Global and Growing Inventory

3. Management of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in the Pan-Arab Region: Consensus Recommendations from a Multidisciplinary Expert Working Group

4. Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy

5. Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region

6. Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study

7. International Variation in Exacerbation Rates in Patients With Severe Asthma

8. Unveiling the Real-World Causal Interaction of Essential Risk Factors in Severe Asthma Exacerbation: A Bayesian Network Analysis

9. Bilirubin detoxification using different phytomaterials: characterization and in vitro studies

10. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

11. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

12. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

13. The ARIA-MeDALL hypothesis

14. Economic burden of refractory chronic spontaneous urticaria on Kuwait's health system

16. Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma

17. Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients

18. Physicians' preferences in the use of PROMs during asthma and allergic rhinitis clinical approach

19. Effectiveness of initiating biologics in severe asthma patients with high steroid exposure

20. Modeling of Cutting Forces in Plunge Milling

21. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

22. Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study.

23. Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy.

24. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

25. Adrenaline autoinjector is underprescribed in typical cold urticaria patients

27. Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study

28. Management of anaphylaxis due to COVID-19 vaccines in the elderly

29. Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.

32. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

33. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

34. The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

35. Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence

37. The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

39. The global burden of chronic urticaria for the patient and society*

42. A Global Survey of Blood Eosinophil Distribution in Severe Asthma Patients: Data from the International Severe Asthma Registry (ISAR)

43. Characterization of Eosinophilic and Non-Eosinophilic Severe Asthma Phenotypes and Proportion of Patients with These Phenotypes in the International Severe Asthma Registry (ISAR)

44. Biologic Utilization Patterns: Data from the International Severe Asthma Registry (ISAR)

45. Global Access for Biologics in the Treatment of Severe Asthma: A Challenge to Personalized Medicine

48. Allergic reactions to penicillins and cephalosporins: diagnosis, assessment of cross-reactivity and management

Catalog

Books, media, physical & digital resources